SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

allergy-asthma

Chronic Hives Treatment: What Works When Antihistamines Don't

Hives that recur daily or near-daily for six weeks or more are called chronic urticaria. When OTC antihistamines are insufficient, prescription-strength antihistamines, add-on therapies, and — for persistent cases — the biologic omalizumab (Xolair) are effective options. An allergist or dermatologist manages ongoing treatment.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is chronic urticaria and why does it happen?

Urticaria — commonly called hives — are raised, itchy welts that appear when mast cells in the skin release histamine and other inflammatory mediators. When hives occur on most days for more than six weeks, they are classified as chronic urticaria. 1

Chronic urticaria has two main subtypes: - Chronic spontaneous urticaria (CSU) — hives appear without a clear external trigger; in many cases, the immune system is misfiring - Chronic inducible urticaria — hives are triggered by a specific physical stimulus such as pressure, cold, heat, or exercise

In the vast majority of chronic spontaneous cases — over 80% — no specific allergen is ever identified. Certain medications (especially NSAIDs like ibuprofen), thyroid autoimmunity, and other autoimmune processes are sometimes associated. A thorough evaluation looks for treatable underlying causes. 12

Why might antihistamines stop working — or not work well enough?

Over-the-counter antihistamines (cetirizine, loratadine, fexofenadine) at standard doses are the first step. 1 For chronic urticaria, clinicians often:

  • Increase the dose — using up to four times the standard dose of a second-generation antihistamine, which guidelines support as safe and more effective for some patients 1
  • Add a second antihistamine — combining agents
  • Add an H2 antihistamine — famotidine (Pepcid) or ranitidine target a different histamine receptor and may add modest benefit when combined with H1 antihistamines

If higher-dose antihistamines still don't control the hives after 2–4 weeks, the next step is typically a specialist referral rather than continuing to try OTC options.

What prescription options exist for chronic hives?

Omalizumab (Xolair) is the most well-supported add-on treatment for chronic spontaneous urticaria that doesn't respond to antihistamines. 12 It is a biologic injection given monthly that reduces the sensitivity of mast cells by binding free IgE. In a landmark randomized controlled trial (the ASTERIA study), the 300-mg omalizumab group achieved a mean weekly itch-severity score reduction of −9.8 versus −5.1 for placebo (P<0.001), with a substantial proportion achieving complete or near-complete control. 3 It is now the standard second-line treatment in international guidelines. 1

Cyclosporine is an immunosuppressant used in cases that don't respond to omalizumab. It has a more significant side effect profile requiring close monitoring and is generally reserved for refractory cases.

Short courses of oral corticosteroids (prednisone) can provide temporary relief during severe flares but are not appropriate for long-term management due to side effects.

Montelukast (a leukotriene modifier) is sometimes used as add-on therapy, though evidence is limited compared to omalizumab.

Should I see an allergist or a dermatologist for chronic hives?

Both allergists and dermatologists treat chronic urticaria. Your choice may depend on who your primary care clinician can refer you to, and whether an allergic cause is suspected.

  • Allergists evaluate whether an underlying allergic trigger, food sensitivity, drug reaction, or autoimmune process is contributing; they are also most familiar with omalizumab and other biologics
  • Dermatologists manage the skin manifestations and may be the appropriate specialist if an autoimmune skin condition is also a concern

A Gale primary care clinician can make the initial assessment, order baseline labs (CBC, thyroid function, inflammation markers) to check for common associated conditions, and coordinate the specialist referral. 2

What should I track before my specialist appointment?

Keeping a symptom diary helps significantly: - When hives appear and how long they last - Where on the body they occur - Any foods, medications, or supplements taken in the hours before - Physical triggers noticed (pressure, exercise, cold, heat) - Any associated throat swelling or breathing changes (angioedema — important to report immediately) - Antihistamines tried, at what doses, and what effect they had

Bringing this record to a specialist appointment makes the evaluation much more efficient. Apps and simple written logs are both effective.

Common questions

Will chronic hives ever go away on their own?

Many cases of chronic spontaneous urticaria do resolve over time, though the timeline varies widely. Studies suggest that a significant proportion of people see resolution within 1–5 years. In the meantime, effective treatment reduces daily burden considerably. The goal of therapy is symptom control and quality of life while the condition runs its course — for some people, treatment continues for years.

Could a food allergy be causing my chronic hives?

It is possible, but less likely than many people assume. Food allergy typically causes hives within minutes to two hours of eating the trigger food, so a pattern of hives that appears on most days without a consistent food link is usually not driven by food allergy. Your allergist will review this carefully, but the investigation usually reveals no specific food trigger in chronic spontaneous urticaria. NSAIDs and aspirin are more commonly implicated than foods.

How is Xolair (omalizumab) given for hives?

Omalizumab for chronic urticaria is given as a subcutaneous (under-the-skin) injection every 4 weeks, usually 300 mg. It is done in the clinic setting for the first injection, with a brief observation period. Some patients respond within days; others take a few months to show full benefit. If it's working, treatment continues for at least 6 months before reassessing.

Are chronic hives dangerous?

Hives themselves are uncomfortable but not dangerous in most cases. The concern arises when hives are accompanied by angioedema — swelling deeper in the tissues, especially in the throat or tongue — or signs of anaphylaxis. These require emergency care. About 40% of people with chronic urticaria also experience angioedema at some point, most commonly in the lips, eyelids, and hands rather than the airway.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

When chronic hives require urgent or emergency care

  • —Swelling of the throat, tongue, or lips (angioedema affecting the airway) — call 911
  • —Difficulty swallowing or speaking — call 911
  • —Shortness of breath or chest tightness with hives — call 911
  • —Hives with dizziness, fainting, or rapid heartbeat — seek emergency care
  • —Facial or throat swelling even without breathing difficulty — seek same-day evaluation

Call 911 for any throat swelling, difficulty breathing, or fainting with hives.

This article provides general health education. Chronic urticaria diagnosis and treatment require assessment by a clinician or specialist. Do not adjust prescription medications without guidance from your provider.

References

  1. 1.Zuberbier T, et al. (2022). The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. doi:10.1111/all.15090 ✓Classification of chronic urticaria, 6-week threshold definition, step-up treatment ladder including high-dose antihistamines and omalizumab as second-line standard
  2. 2.Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. (2014). The diagnosis and management of acute and chronic urticaria: 2014 update. Journal of Allergy and Clinical Immunology. doi:10.1016/j.jaci.2014.02.036 ✓Diagnostic evaluation for chronic urticaria; role of allergist evaluation; omalizumab for antihistamine-refractory cases
  3. 3.Maurer M, Rosén K, Hsieh HJ, et al. (2013). Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New England Journal of Medicine. doi:10.1056/NEJMoa1215372 ✓Landmark RCT (ASTERIA): omalizumab 300 mg achieved a mean itch-severity score reduction of −9.8 vs −5.1 for placebo (P<0.001) in chronic spontaneous urticaria unresponsive to antihistamines

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.